Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP603770.RAaxI66wNj-8hOxKms0MNmYRh5EvkOvUei0QKNV-VpzUA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP603770.RAaxI66wNj-8hOxKms0MNmYRh5EvkOvUei0QKNV-VpzUA130_assertion type Assertion NP603770.RAaxI66wNj-8hOxKms0MNmYRh5EvkOvUei0QKNV-VpzUA130_head.
- NP603770.RAaxI66wNj-8hOxKms0MNmYRh5EvkOvUei0QKNV-VpzUA130_assertion description "[TLR-2, TLR-1 and TLR-6 were expressed on both HPKs from patients with AD as well as healthy controls without significant differences between these groups.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP603770.RAaxI66wNj-8hOxKms0MNmYRh5EvkOvUei0QKNV-VpzUA130_provenance.
- NP603770.RAaxI66wNj-8hOxKms0MNmYRh5EvkOvUei0QKNV-VpzUA130_assertion evidence source_evidence_literature NP603770.RAaxI66wNj-8hOxKms0MNmYRh5EvkOvUei0QKNV-VpzUA130_provenance.
- NP603770.RAaxI66wNj-8hOxKms0MNmYRh5EvkOvUei0QKNV-VpzUA130_assertion SIO_000772 21447101 NP603770.RAaxI66wNj-8hOxKms0MNmYRh5EvkOvUei0QKNV-VpzUA130_provenance.
- NP603770.RAaxI66wNj-8hOxKms0MNmYRh5EvkOvUei0QKNV-VpzUA130_assertion wasDerivedFrom befree-20140225 NP603770.RAaxI66wNj-8hOxKms0MNmYRh5EvkOvUei0QKNV-VpzUA130_provenance.
- NP603770.RAaxI66wNj-8hOxKms0MNmYRh5EvkOvUei0QKNV-VpzUA130_assertion wasGeneratedBy ECO_0000203 NP603770.RAaxI66wNj-8hOxKms0MNmYRh5EvkOvUei0QKNV-VpzUA130_provenance.